Suppr超能文献

伽玛刀放射外科治疗肺癌多发脑转移瘤

Gamma knife radiosurgery for multiple brain metastases from lung cancer.

作者信息

Park Seong-Hyun, Hwang Sung-Kyoo, Kang Dong-Hun, Lee Sun-Ho, Park Jaechan, Hwang Jeong-Hyun, Hamm In-Suk, Park Yeun-Mook

机构信息

Department of Neurosurgery, BioMedical Research Institute, Kyungpook National University Hospital 50, Samduk-2-ga, Jung-gu, Daegu 700-721, South Korea.

出版信息

J Clin Neurosci. 2009 May;16(5):626-9. doi: 10.1016/j.jocn.2008.08.003. Epub 2009 Mar 5.

Abstract

The aim of this study was to compare the effectiveness of gamma knife radiosurgery (GKS) for the treatment of multiple brain metastases from lung cancer with that of whole brain radiation therapy (WBRT). Patients with multiple (2-20) brain metastases were divided into two groups for initial brain tumor management: a GKS group (14 patients) and a WBRT group (19 patients). The patients were stratified by gender, age, initial Karnofsky performance status score, control of the primary site, known extracranial metastases, number of brain metastases, diameter of the maximal lesion, chemotherapy, and recursive partitioning analysis (RPA) Class. The 6-month and 1-year overall survival rates were 64.3% and 47.7%, respectively, in the GKS group, and 42.1% and 10.5%, respectively, in the WBRT group. The median survival time was 32 weeks in the GKS group and 24 weeks in the WBRT group. The overall survival time in the GKS group was significantly longer than in the WBRT group (p=0.04). The univariate analysis suggests that survival was increased in both patients with a controlled primary tumor site and in the GKS group (p=0.03, 0.04). The use of GKS in patients with multiple brain metastases significantly improved patient survival compared to the employment of WBRT. When we assessed the subgroups, systemic disease control and GKS were significant variables by univariate analysis.

摘要

本研究的目的是比较伽玛刀放射外科治疗(GKS)与全脑放射治疗(WBRT)对肺癌多发脑转移瘤的治疗效果。将有2至20个脑转移瘤的患者分为两组进行初始脑肿瘤治疗:GKS组(14例患者)和WBRT组(19例患者)。患者按性别、年龄、初始卡氏功能状态评分、原发部位控制情况、已知颅外转移情况、脑转移瘤数量、最大病灶直径、化疗情况及递归分区分析(RPA)分级进行分层。GKS组6个月和1年的总生存率分别为64.3%和47.7%,WBRT组分别为42.1%和10.5%。GKS组的中位生存时间为32周,WBRT组为24周。GKS组的总生存时间显著长于WBRT组(p = 0.04)。单因素分析表明,原发肿瘤部位得到控制的患者以及GKS组患者的生存率均有所提高(p = 0.03,0.04)。与采用WBRT相比,对多发脑转移瘤患者使用GKS可显著提高患者生存率。在评估亚组时,单因素分析显示全身疾病控制和GKS是显著变量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验